These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

39 related items for PubMed ID: 19778718

  • 21. Synthesis, biophysical characterization, and anti-HIV-1 fusion activity of DNA helix-based inhibitors with a p-benzyloxyphenyl substituent at the 5'-nucleobase site.
    Tang Y, Han Z, Guo J, Tian Y, Liu K, Xu L.
    Bioorg Med Chem Lett; 2018 Jun 01; 28(10):1842-1845. PubMed ID: 29680665
    [Abstract] [Full Text] [Related]

  • 22. Peptides come round: using SICLOPPS libraries for early stage drug discovery.
    Lennard KR, Tavassoli A.
    Chemistry; 2014 Aug 18; 20(34):10608-14. PubMed ID: 25043886
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction.
    Shiheido H, Takashima H, Doi N, Yanagawa H.
    PLoS One; 2011 Mar 15; 6(3):e17898. PubMed ID: 21423613
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.
    Jiang S, Tala SR, Lu H, Zou P, Avan I, Ibrahim TS, Abo-Dya NE, Abdelmajeid A, Debnath AK, Katritzky AR.
    Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6895-8. PubMed ID: 21978673
    [Abstract] [Full Text] [Related]

  • 30. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD.
    AIDS Rev; 2003 Nov 15; 5(4):214-21. PubMed ID: 15012000
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Making strides in peptide-based therapeutics.
    Guarracino DA, Arora PS.
    Chem Biol; 2009 Sep 25; 16(9):919-20. PubMed ID: 19778718
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD.
    AIDS Rev; 2003 Sep 25; 5(4):214-21. PubMed ID: 15012000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [New Search]
    of 2.